Skip to content

Coping strategies in adults with a diagnosis of refractory epilepsy: Development, antecedents, and consequences.

Coping strategies in adults with a diagnosis of refractory epilepsy: Development, antecedents, and consequences. - Coping in adults with refractory epilepsy.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43395
Enrollment
300
Registered
2016-04-18
Start date
2016-09-29
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

convulsion epilepsy seizures

Interventions

None listed

Sponsors

Universiteit van Tilburg
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with a diagnosis of refractory epilepsy in the age range of 18-40 years with a sufficient knowledge of the Dutch language, no other chronic illness, and an estimated IQ above 70.

Exclusion criteria

Exclusion criteria: Exclusion criteria include mental retardation or cognitive delays which makes patients incapable of filling out the questionnaires, presence of another chronic illness, insufficient knowledge of the Dutch language, no available contact information, no written consent.

Design outcomes

Primary

MeasureTime frame
The primary study parameter of the study is coping strategies and hypothesized antecedents (i.e., executive functioning, illness identity and perceptions, and personality) and consequences (i.e., quality of life and seizure frequency/severity).

Secondary

MeasureTime frame
Secondary study parameters of the study are demographic and clinical variables: gender, age (date of birth), level of education, employment status, ethnic background, marital status, age of onset of the epilepsy, type of epilepsy, medication use, epilepsy surgery (yes/no), psychogenic non-epileptic seizures (PNES) (yes/no).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)